Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline
NCT03640507 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2020-06-09
Summary
The purpose of this study is to see whether chlorhexidine is superior to povidine-iodine vaginal antisepsis at reducing bacteria colony counts in pregnant women by comparing three groups: vaginal washing with chlorhexidine-alcohol, vaginal washing with povidine-iodine, and vaginal washing with saline alone.
Conditions
- Cesarean Section; Infection
- Surgical Site Infection
Interventions
- DRUG
-
Sterile saline
Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.
- DRUG
-
Chlorhexidine-alcohol
Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.
- DRUG
-
Povidine-iodine
Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Yiping Han, PhD · Columbia University Department of Microbiology and Immunology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2019-05-08
- Completion
- 2019-06-14
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Vaginal Prep Solutions to Reduce Bacteria Colony Counts in Patients Having a Vaginal Surgery
NCT03854370 ·Status: TERMINATED ·Phase: NA
-
Vaginal Hygiene Wash as Adjunct Treatment in Bacterial Vaginosis
NCT04846361 ·Status: UNKNOWN ·Phase: NA
-
Impact of Maternity Napkins on the Incidence of Vaginal Infections in the Post-partum Period
NCT05806879 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis
NCT03091777 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV)
NCT03769688 ·Status: WITHDRAWN ·Phase: PHASE1
-
Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
NCT00706368 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability of Metronidazole Gel 1.3%
NCT02392026 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Gynecological Acceptability of a Health Care Product
NCT04247022 ·Status: COMPLETED ·Phase: NA
-
Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users
NCT03261804 ·Status: COMPLETED
-
Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
NCT00542074 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
NCT06983041 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Gynecological Acceptability of 3 Health Care Products
NCT04327947 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
NCT02709005 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)
NCT01201057 ·Status: COMPLETED ·Phase: PHASE2
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
NCT05753813 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
NCT06070454 ·Status: RECRUITING ·Phase: NA
-
Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
NCT01020396 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)
NCT01437722 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis
NCT01577537 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Lactic Acid Gel for Intravaginal Use, 7 Applicators x 5ml, Bayer to Reduce Post-episiotomy Discomfort
NCT06978049 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of SPL7013 Gel (VivaGel) for the Treatment of Bacterial Vaginosis
NCT01577238 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Vaginal Washing on Cervical Inflammation
NCT06615232 ·Status: RECRUITING ·Phase: NA
-
Improving Menstrual and VAginal Health for All
NCT06646185 ·Status: RECRUITING ·Phase: NA
-
Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis
NCT02687789 ·Status: COMPLETED ·Phase: NA
-
EFFICACY AND SAFETY OF OVA AND LAVAGE MEDICAL DEVICES IN THE TREATMENT OF NON-SPECIFIC VULVOVAGINITIS
NCT05649735 ·Status: COMPLETED ·Phase: NA